To develop an ex vivo model for the analysis of macroscopic, histological and immunohistochemical changes after experimental endovenous laser ablation (EVLA) of the great saphenous vein (GSV).
Introduction
Chronic venous insufficiency caused by varicose veins is a common medical condition, with prevalence rates ranging as high as 28% to 35% in adults 1 . Morbidity and patient dissatisfaction associated with conventional surgical treatment of great saphenous vein (GSV) reflux, which includes high ligation at the saphenofemoral junction (SFJ) combined with stripping of the GSV, have led to the development of alternative techniques 2 . Currently, endovenous treatment is preferred to conventional surgical treatment, and several successful treatment options are available for patients with chronic venous insufficiency caused by varicose veins. Because of the various options available, many physicians have had difficulties in choosing the best method that meets their patients' needs. In addition, the inter-method variability of protocols and parameters used in endovenous treatment should also be considered, as these factors might hinder effective decision-making.
If on the one hand this variability may lead to different opinions about which method of endovenous treatment is the best choice, on the other hand it should prompt research on and development of standards for the use of these methods. Innovative concepts and alternative treatments should therefore be developed, tested and evaluated until their approval for clinical use. In this context, experimental models are useful tools to investigate the mechanisms involved in endovenous laser ablation (EVLA) procedures because they can mimic basic processes that occur in GSV reflux and provide an alternative to studies in humans and in animal models.
Experimental models may also be used for training purposes and scientific research, allowing the analysis of acute effects on ablated veins based on macroscopic, histological and immunohistochemical findings. In addition, these models do not require the same approval process as research involving animals or human subjects, thus minimizing ethical concerns and reducing the costs for implementation.
In order to investigate the mechanisms involved in EVLA and to test treatment strategies, the aim of the current study was to develop a simple ex vivo model of EVLA of the GSV that mimics the physiological conditions of the procedure, such as tumescence and blood flow, and to evaluate macroscopic, histological and immunohistochemical changes in the ablated GSV segment.
Methods
This was a descriptive study using an experimental design. The study was approved on June 1, 2015 by the Research Ethics Committee of Hospital Angelina Caron, a teaching hospital affiliated with Universidade Federal do Paraná (project approval No. 45209015.9.0000.5226). All experiments were conducted in accordance with the National Institutes of Health guidelines.
Ex vivo model of EVLA of the GSV
The materials used to produce the experimental model are shown in Figure 1 . To prepare the experimental model, initially we cut open a glass tube at both ends ( Figure 2A ) and insert the 8F introducers with hemostatic valve through the rubber stoppers ( Figure 2B ). The vein to be studied is then passed through the glass tube and stretched, and its ends are fixed in the introducer sheaths with 2-0 cotton sutures ( Figure 2C ). Then, the rubber stoppers are placed at both ends of the tube ( Figure 2D ) and 0.9% saline solution is infused into the system through the infusion port of one of the introducers ( Figure 2E ), followed by puncture of one of the rubber stoppers with a hypodermic needle and infusion of saline into the space around the vein (tumescence) ( Figure 2F ). A digital probe thermometer is also inserted through one of the rubber stoppers ( Figure 2G ). The laser fiber or radiofrequency ablation catheter is introduced into the vein through one of the introducers ( Figure  2H ) and blood is then injected through the infusion port of the introducer and content is aspirated through the other infusion port to simulate continuous blood flow ( Figure 2I ). At this point, physiological conditions are established and EVLA can be initiated ( Figure 2J ).
FIGURE 2 -
Steps to prepare the experimental model. A) Glass tube cut open at both ends; B) 8F introducers with hemostatic valve inserted into the rubber stoppers; C) Vein is passed through the glass tube, stretched, and fixed at both ends in the introducer sheaths; D) Rubber stoppers placed at both ends of the tube; E) Infusion of 0.9% saline into the system; F) Puncture of one of the rubber stoppers and infusion of saline into the space around the vein (tumescence); G) Digital probe thermometer inserted into one of the rubber stoppers; H) Laser fiber or radiofrequency ablation catheter is passed through one of the introducers; I) Blood is injected through the infusion port of the introducer and content is aspirated through the other infusion port to simulate continuous blood flow; J) Final ex vivo endovenous laser ablation model.
Pilot study
To assess the reproducibility of the experimental model, a pilot study was conducted to evaluate an ex vivo procedure of At the laboratory, the section was dehydrated in alcohol and embedded in paraffin. Slices were made and stained using the following techniques: hematoxylin & eosin (H&E) staining for analysis of tissue morphology, elastic fiber histochemistry for quantification of these proteins, Gomori's trichrome staining for quantification of muscle fibers, and alpha-smooth muscle actin immunohistochemistry for quantification of muscle fibers and expression of the specific marker for this cell type. These techniques allow better visualization of smooth muscle fibers and elastic fibers that make up the wall of the ablated vein.
Slides were evaluated in triplicate, using the color deconvolution plugin for Image J software to separate colors in photomicrographs. A quantitative analysis was performed on 10 fields in each slide.
Results
No perforations were observed macroscopically in the GSV segment subjected to EVLA in the pilot study. Confirming this macroscopic finding, no perforations were observed in the microscopic evaluation of this segment by several histological and immunohistochemical methods. In Gomori's trichrome staining, the positive reaction for muscle fibers is stained in brown or red. In the analysis of the central part of the ablated GSV, only a small amount of red staining (muscle fibers) was observed ( Figure 5 ). In the immunohistochemical expression of alphasmooth muscle actin, when horseradish peroxidase (HRP) and diaminobenzidine (DAB) are used as markers, brown precipitates are formed where there is interaction with the specific antibody.
In the pilot study, disruption of muscle fibers associated with a reduced expression of the specific marker for this cell type was observed in the central part of the GSV segment subjected to EVLA ( Figure 6 ). FIGURE 6 -Immunohistochemical expression of alpha-smooth muscle actin in the central part of the saphenous vein subjected to endovenous laser ablation: A) magnification ×100 and B) magnification ×200. Note the disruption of muscle fibers and a reduced expression of the specific marker for this cell type.
Discussion
The present study investigated an experimental model that allowed the ex vivo performance of EVLA of the GSV and subsequent analysis of macroscopic, histological and immunohistochemical changes in the ablated GSV segment.
New EVLA techniques allow adjustment and combination of multiple parameters that need to be tested and investigated systematically. These techniques should first be tested experimentally under reproducible conditions, especially taking into account macroscopic and histological changes in tissues undergoing EVLA.
Some EVLA parameters are known to affect the outcomes of patients treated with this technique. These parameters include power, wavelength, linear endovenous energy density (LEED), and type of laser fiber 3 .
To reduce possible side effects of EVLA (such as pain, paresthesia, and bruising), devices operating at higher wavelengths and using different types of laser fiber have been developed. Theoretically, higher wavelengths target the interstitial water in the vessel wall as the chromophore, reducing side effects 4 .
Because the use of a conventional bare-tip fiber often leads to uneven application of energy in the vein wall, resulting in local perforation and uneven destruction of the perivenous tissues, new fibers have been developed in order to reduce these effects [5] [6] [7] .
EVLA at low energy densities results in lower occlusion rates and higher recurrence rates than higher energy EVLA 8, 9 .
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Limitations
Although ex vivo experiments look promising, they have some limitations, including: the vein segment may undergo some changes during harvesting; analysis of only immediate effects of the treatment; and inability to study the perivascular tissue.
Conclusions
The ex vivo endovenous laser ablation model described here is suitable for use in scientific research and for medical training purposes considering the use of different EVLA parameters. In addition, it may be used for preclinical testing based on acute macroscopic, histological and immunohistochemical findings. It is therefore a low cost alternative to in vivo experiments, providing standardized experimental conditions.
